We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Single Test Panel to Detect Six Respiratory Viruses

By HospiMedica staff writers
Posted on 18 Nov 2004
New analyte-specific reagents (ASRs) are designed to allow clinical reference laboratories to develop and validate a single test panel for detecting six of the most common respiratory viruses.

The gene-based viral ASRs will enable laboratories to develop a test for influenza A, influenza B, human parainfluenza 1, human parainfluenza 2, human parainfluenza 3, and respiratory syncytial virus A/B in a single panel. More...
The ASRs also give labs the capability to develop a test that can detect dual infections, which formerly required additional time and tests.

The respiratory viral ASRs were developed by Nanogen (San Diego, CA, USA) and incorporate multiplexing technology developed by Prodesse, Inc. (Waukesha, WI, USA). The reagents on the recently introduced NanoChip 400 can provide clinical labs with an advanced microarray platform to develop gene-based tests that can generate results in one day versus culture-based tests that can take a week. Also, the ASRs can be validated by labs for use with their current sample preparation methodologies, streamlining workflow.

"Nanogen is entering the large marketplace for infectious disease with a highly sensitive rapid approach that far exceeds the capabilities of standard culture-based tests,” said Howard C. Birndorf, chairman and CEO of Nanogen.




Related Links:
Nanogen

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Medical Examination & Procedure Light
Vega 80
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new, inexpensive stick-on sweat sensor measures lipid levels, offering a noninvasive way to continuously monitor cholesterol and triglycerides. (Image Credit: California Institute of Technology)

Wearable Patch Enables Continuous Noninvasive Cholesterol and Triglyceride Monitoring

Cholesterol and triglyceride testing typically relies on phlebotomy and intermittent lipid panels, limiting real-time assessment of cardiovascular and metabolic risk. Noninvasive monitoring could reduce... Read more

Surgical Techniques

view channel
Image: Phasix Mesh is a fully resorbable monofilament scaffold designed for rapid tissue incorporation, combining synthetic mesh repair strength with biologic graft-like remodeling. (Photo courtesy of BD)

Resorbable Mesh Evaluated to Prevent Incisional Hernias After Abdominal Surgery

Incisional hernia is a common complication after abdominal surgery and can necessitate additional interventions and prolonged recovery. Preventive strategies remain limited, and there are currently no... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.